Display options
Cite
Bourguiba R, Delplanque M, Vinit C, et al. Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area. Ann Rheum Dis. 2020;doi: 10.1136/annrheumdis-2020-218707.
Bourguiba, R., Delplanque, M., Vinit, C., Ackermann, F., Savey, L., Grateau, G., Hentgen, V., & Georgin-Lavialle, S. (2020). Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area. Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2020-218707
Bourguiba, Rim, et al. "Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area." Annals of the rheumatic diseases vol. (2020). doi: https://doi.org/10.1136/annrheumdis-2020-218707
Bourguiba R, Delplanque M, Vinit C, Ackermann F, Savey L, Grateau G, Hentgen V, Georgin-Lavialle S. Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area. Ann Rheum Dis. 2020 Nov 02; doi: 10.1136/annrheumdis-2020-218707. Epub 2020 Nov 02. PMID: 33139307.
Copy Download .nbib Format: NLM
Share it on

Ann Rheum Dis. 2020 Nov 02; doi: 10.1136/annrheumdis-2020-218707. Epub 2020 Nov 02.

Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area.

Annals of the rheumatic diseases

Rim Bourguiba, Marion Delplanque, Caroline Vinit, Felix Ackermann, Léa Savey, Gilles Grateau, Veronique Hentgen, Sophie Georgin-Lavialle

Affiliations

  1. Sorbonne Université, AP-HP, DMU3ID, Tenon hospital, Internal medicine department, national reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), Paris, France.
  2. General pediatry department, Versaille hospital, André-Mignot, General pediatry department, National reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), versailles, France.
  3. Department of Internal Medicine, Hopital Foch, Sursennes, France.
  4. Sorbonne Université, AP-HP, DMU3ID, Tenon hospital, Internal medicine department, national reference center of autoinflammatory diseases and inflammatory amyloidosis (CEREMAIA), Paris, France [email protected].

PMID: 33139307 DOI: 10.1136/annrheumdis-2020-218707

[No abstract available.]

Keywords: amyloidosis; familial Mediterranean fever; inflammation

Conflict of interest statement

Competing interests: None declared.

Publication Types